Tag:
Perrigo
Latest Headlines
Latest Headlines
Zacks rewards Perrigo's speedy QA turnaround
Zacks likes Perrigo, and why not? Active pharmaceutical ingredient sales are up 26 percent over a year ago, to $41 million. But even more impressive is how the recently quality-challenged generics
J&J, generics makers to revamp children's Tylenol products
Tylenol maker Johnson & Johnson will revamp its product line for infants and children to help prevent overdoses of the pain and fever remedy. The company plans to make all children's Tylenol
FDA's OK of Perrigo plant signals SOP fixes
The FDA's all-clear sign for Perrigo's Michigan manufacturing plant this week is in some ways an understatement of what must have happened there. Inspectors arrived on March 1 and Perrigo announced
Perrigo gets FDA clearance at troubled plant
A year after receiving a warning from regulators, generics maker Perrigo said its manufacturing facility in Allegan, MI, has won FDA's approval. Report
Perrigo looking to hire
Good news for Michigan workers--Perrigo is looking to hire. The generic drugmaker will announce plans today to hire 100 new employees at its Allegan complex. This is on top of 70 new hires in
Perrigo execs on the hot seat following FDA warning
Uh, oh: Here's an ominous line from the recently posted FDA warning letter to Perrigo, a Michigan manufacturer of non-prescription, store-branded drugs: "Be advised that FDA expects that your
FDA slams Perrigo for metal-tainted tablets
With Johnson & Johnson's consumer healthcare unit partially sidelined by a big recall, you'd think it would be a prime opportunity for Perrigo, which churns out generic versions of many of the
Perrigo loses $400K in drug shipment theft
It's turning out that March was a good month for drug heists. A $400,000 truckload of Perrigo medications was swiped near Dallas early in the month, preceding by about two weeks Eli Lilly's
India is hot for mid-size pharma, too
We've kept close tabs on Big Pharma's moves into emerging markets. But as India's Business Standard notes, it's not just Big Pharma that's moving into the subcontinent in a big way. Mid-size
ALSO NOTED: Perrigo, Teva get clearance for generic Zyrtec-D; Pfizer sues Impax over copycat Detrol;
> Perrigo and its partner Teva Pharmaceutical Industries got the FDA nod for their over-the-counter version of McNeil Consumer Healthcare's Zyrtec-D; McNeil, a Johnson & Johnson unit, launched
